<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01789918</url>
  </required_header>
  <id_info>
    <org_study_id>CLIN-0030-HT</org_study_id>
    <nct_id>NCT01789918</nct_id>
  </id_info>
  <brief_title>TrAnsCatHeter Intravascular Ultrasound Energy deliVery for rEnal Denervation (ACHIEVE)</brief_title>
  <acronym>ACHIEVE</acronym>
  <official_title>TrAnsCatHeter Intravascular Ultrasound Energy deliVery for rEnal Denervation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ReCor Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ReCor Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ACHIEVE study is a single-arm, open-label, prospective, post-market follow-up study to
      include up to one hundred (100) eligible patients as defined within the clinical
      investigational plan, with a twelve month follow-up period. The ACHIEVE study was originally
      designed in accordance with the 2007 ESH ESC guidelines for resistant hypertension.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients with device- or procedure-related adverse events</measure>
    <time_frame>12 months</time_frame>
    <description>Anticipated adverse events include:
Access site and access-related vascular injury
Renal artery complications, including: stenosis, aneurysm, dissection, and perforation
Renal complications, including: renal infarction, acute kidney injury, and renal failure
Arterial and venous thromboembolic events, including: myocardial infarction, stroke or transient ischemic attack, pulmonary embolism, and deep vein thrombosis
Systemic effects, including: allergic reaction and infection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in systolic blood pressure</measure>
    <time_frame>12 months</time_frame>
    <description>Change from baseline in systolic blood pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in diastolic blood pressure</measure>
    <time_frame>12 months</time_frame>
    <description>Change from baseline in diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in anti-hypertensive medication intake</measure>
    <time_frame>12 months</time_frame>
    <description>Change from baseline in anti-hypertensive medication intake</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from baseline in pulse pressure and nocturnal dipping</measure>
    <time_frame>12 months</time_frame>
    <description>Changes from baseline in pulse pressure and nocturnal dipping</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change from baseline in EQ-5D Quality of Life score</measure>
    <time_frame>12 months</time_frame>
    <description>Change from baseline in EQ-5D Quality of Life score</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline in cardiac function</measure>
    <time_frame>12 months</time_frame>
    <description>Change from baseline in cardiac function</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Resistant Hypertension</condition>
  <arm_group>
    <arm_group_label>Percutaneous renal denervation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PARADISE percutaneous renal denervation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PARADISE percutaneous renal denervation</intervention_name>
    <description>Intravascular ultrasound emission</description>
    <arm_group_label>Percutaneous renal denervation</arm_group_label>
    <other_name>ReCor Medical PARADISE</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Resistant hypertension, as defined in the 2007 ESH-ESC guidelines

          -  18 years of age or older

          -  Negative pregnancy test for female patients of childbearing potential

          -  Willing and able to comply with follow-up requirements

          -  Signed informed consent

        Exclusion Criteria:

          -  Secondary hypertension

          -  Main renal arteries length &lt; 20 mm

          -  Main renal arteries diameter &lt; 4 mm

          -  Renal artery stenosis

          -  Iliac/femoral artery stenosis precluding insertion of the catheter

          -  Untreated allergy to contrast media

          -  Currently participating in the study of an investigational drug or device

          -  Moderate to severe renal insufficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Zeller, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitäts-Herzzentrum Freiburg • Bad Krozingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitäts-Herzzentrum Freiburg • Bad Krozingen</name>
      <address>
        <city>Bad Krozingen</city>
        <zip>79189</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CardioVasculäres Centrum</name>
      <address>
        <city>Frankfurt</city>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik St. Georg</name>
      <address>
        <city>Hamburg</city>
        <zip>20099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum des Saarlandes</name>
      <address>
        <city>Homburg/Saar</city>
        <zip>66424</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Lübeck</name>
      <address>
        <city>Lübeck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus MC - Thoraxcenter</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska Universitetssjukhuset</name>
      <address>
        <city>Göteborg</city>
        <zip>413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Sweden</country>
  </location_countries>
  <removed_countries>
    <country>Belgium</country>
    <country>Switzerland</country>
  </removed_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2013</study_first_submitted>
  <study_first_submitted_qc>February 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2013</study_first_posted>
  <last_update_submitted>April 4, 2016</last_update_submitted>
  <last_update_submitted_qc>April 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Renal denervation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

